Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India-Reference-Cited by-同舟云学术

Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India

Published:2022-05 Issue: Volume:Volume 13 Page:33-41
ISSN:1179-7266
Container-title:Pragmatic and Observational Research
language:en
Short-container-title:POR

Author:

Joshi Shashank,Vora Agam,Venugopal K,Dadhich Pramod,Daxini Anil,Bhagat Sagar,Patil Saiprasad,Barkate Hanmant

Publisher

Informa UK Limited

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference23 articles.

1. World Health Organization. IHR emergency committee on novel coronavirus (2019-nCoV) [internet]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov);. Accessed June 27, 2021.

2. World Health Organization. Coronavirus (COVID-19) Dashboard [Internet]. Available from: https://covid19.who.int/. Accessed April 25, 2022.

3. Role of favipiravir in the treatment of COVID-19

4. Approval of favipiravir tablets to Glenmark Pharmaceuticals and Remdesivir Injection to Cipla Ltd, Hetero Drugs and Mylan Labs. Available from: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NjIxMw==;. Accessed June 16, 2021.

5. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors of the Structural and Nonstructural Proteins of Alphaviruses;ACS Infectious Diseases;2024-07-12

2. In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity;Archiv der Pharmazie;2023-10-18

3. Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial);Phytomedicine;2023-10

4. Tautomerism and Rotamerism of Favipiravir and Halogenated Analogues in Solution and in the Solid State;The Journal of Organic Chemistry;2023-07-15

5. The Efficacy and Safety of Imusil® Tablets in the Treatment of Adult Patients With Mild COVID-19: A Prospective, Randomized, Multicenter, Open-Label Study;Cureus;2023-03-07